Purchase Order 75D30123P17788
Award Date
9/6/23
Potential Completion Date
9/29/27
Potential Value
$100K
Federal Agency
CDC Pittsburgh
Awardee
Vela Diagnostics USA Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Vela Diagnostics USA Inc. for $31,206.40 to procure Sentosa SQ HIV genotyping reagent kits and consumables. This sole source award is for the FDA-approved Next Generation Sequencing (NGS) HIV-1 drug resistance assay, which Vela Diagnostics is the sole manufacturer of. The place of performance is Fairfield, New Jersey. This award is not associated with a larger contract vehicle and does not have a...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Vela Diagnostics USA Inc., a global provider of integrated molecular diagnostic solutions. The contract, valued at $1,439,264.40, is for the rental of a VELA SQ SENTOSA Next Generation Sequencing (NGS) System. This equipment and associated services will support critical public health initiatives through the provision of leading diagnostic technologies. The contract does not have a set-aside designation....
This federal contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to Vela Diagnostics USA Inc., a for-profit organization, for the VELA DIAGNOSTICS VIROKEY SENTOSA requirement. The award, made on January 13, 2021, is a firm-fixed-price purchase order with a potential value of $436,564.36 and a completion date of December 31, 2021. The contract does not have a set-aside designation. Through this award, Vela Diagnostics...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price purchase order to Vela Diagnostics USA Inc., a for-profit organization, to provide viral next-generation sequencing (NGS) testing for genotyping and resistance of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) at a cost of $148,104.85. The contract, which was not set aside, has a completion date of September 30, 2022. Vela Diagnostics USA Inc. has previously provided federal agencies,...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to Vela Diagnostics USA Inc., a for-profit organization, for the provision of laboratory testing equipment. The contract has a total small business set-aside designation and a potential value of $149,000.00. It supports the national interest action code for the Coronavirus COVID-19 response. Through past prime federal contract awards,...
Vela Diagnostics USA Inc. was awarded a $185,261 firm fixed-price purchase order by the Centers for Disease Control and Prevention (CDC) to provide VELA Diagnostics equipment. The CDC, a component of the Department of Health and Human Services, works to protect public health and safety through the control and prevention of disease, injury, and disability. This award was made directly without a set-aside designation and calls for the equipment to be delivered to a location in Fairfield, New...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Vela Diagnostics USA Inc. to provide COVID-19 VELA TESTING REAGENTS AND CONSUMABLES. The contract, with a potential value of $184,029.47, has a completion date of June 25, 2021 and was awarded on June 11, 2020. This award, which did not have a set-aside, was made in support of the Coronavirus COVID-19 national interest action. Vela Diagnostics USA Inc. is a for-profit organization...
The U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a firm-fixed-price contract to Vela Diagnostics USA Inc. for the research and development of a probe-based reverse transcriptase polymerase chain reaction (RT-PCR) test for COVID-19. The contract, which was not set aside, has a potential value of $224,780 and a completion date of October 31, 2020. Vela Diagnostics USA Inc. is a global provider of integrated molecular...
The U.S. Department of Veterans Affairs awarded a firm-fixed-price purchase order to Vela Diagnostics USA Inc. for the delivery of SARS-CoV-2 test reagents. The contract, valued at $86,922.21, has an ultimate completion date of October 8, 2021. Vela Diagnostics USA Inc. is a for-profit organization that has previously provided equipment rental, reagents, consumables, and research and development to support COVID-19 testing, HIV genotyping, and next-generation sequencing systems for various...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $18,854.28 contract supports the development and validation of new HIV genotyping assays that enable monitoring tools for managing the treatment of HIV-positive patients. This work does not have a set-aside designation. The contract has an ultimate completion date of August 5, 2029....